A Brief Values Intervention to Support Veterans in Early Buprenorphine Treatment

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Dependence, Opioid
Interventions
BEHAVIORAL

Brief, values based intervention for early buprenorphine treatment

The initial intervention structure consists of four weekly sessions. Session one focuses on values clarification using an empirically validated clinical exercise. The second session will include a discussion of the connection between values, addiction treatment engagement, and the challenges associated with discomfort (i.e., withdrawal and cravings) in early treatment. The third session will focus on barriers and goal setting to enhance self-efficacy for committed action. The final session will review progress made and focus on the Veterans' recovery plan moving forward. The initial study intervention will be refined iteratively using Phase 1 stakeholder and Phase 2 open trial participant feedback.

BEHAVIORAL

Treatment as Usual

Veterans will be recruited from an intensive treatment phase where all Veterans receive case management and regular group therapy in addition to appointments with their buprenorphine, methadone, or naltrexone prescriber. After the first two weeks, they have the option to continue with a less intensive group schedule and case management support through an Aftercare program.

Trial Locations (1)

01730-1114

RECRUITING

VA Bedford HealthCare System, Bedford, MA, Bedford

All Listed Sponsors
lead

VA Office of Research and Development

FED